Makoto Ota
Founder presso WELBE, INC.
Patrimonio netto: 39 M $ in data 31/03/2024
Profilo
Makoto Ota is the founder of Welbe, Inc. where he holds the title of President & Representative Director since 2011.
He is currently a Director at Welbe Healthcare, Inc. since 2021.
Mr. Ota was also a Director at tella, Inc. in the past.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
WELBE,INC.
20.00% | 27/03/2024 | 5 512 154 ( 20.00% ) | 39 M $ | 31/03/2024 |
Posizioni attive di Makoto Ota
| Società | Posizione | Inizio |
|---|---|---|
| WELBE, INC. | Founder | 01/12/2011 |
| Welbe Healthcare, Inc. | Director/Board Member | 01/06/2021 |
Precedenti posizioni note di Makoto Ota
| Società | Posizione | Fine |
|---|---|---|
| TELLA, INC. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| WELBE, INC. | Commercial Services |
| Aziende private | 2 |
|---|---|
| Welbe Healthcare, Inc. | Health Services |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Borsa valori
- Insiders
- Makoto Ota
